<DOC>
	<DOCNO>NCT01729611</DOCNO>
	<brief_summary>Pulmonary arterial hypertension ( PAH ) condition characterize increase pulmonary vascular resistance lead right heart failure death . Several disease know etiology PAH include scleroderma cirrhosis . The presence PAH context systemic sclerosis cirrhosis dramatic impact prognosis survival connective tissue liver disease . Despite advance diagnosis PAH , echocardiography remain necessary test screen PAH patient scleroderma cirrhosis . However , echocardiography less ideal diagnosing PAH predict treatment response . Thus , press need identify methodology accurately non-invasively recognize presence PAH patient scleroderma cirrhosis . Hypothesis : 1 . To measure endothelial function exhale gas patient scleroderma cirrhosis . To assess whether correlate presence development PAH . 2 . The degree local ( forearm ) capillary vasodilation treprostinil iontophoresis identifies patient develop PAH already diagnose PAH predicts response PAH-specific therapy .</brief_summary>
	<brief_title>Endothelial Function Patients With Scleroderma Cirrhosis With Without Pulmonary Hypertension</brief_title>
	<detailed_description>Patients scleroderma know endothelial dysfunction limit data suggest association degree endothelial function scleroderma presence PAH . However , data preliminary use predict response PAH-specific therapy development PAH . We test patient cirrhosis tend PAH context hyperdynamic instead hypodynamic state observe scleroderma PAH . Aims : 1 . To measure endothelial function exhale gas patient scleroderma cirrhosis ass whether correlate presence development PAH . 2 . To evaluate degree endothelial response local treprostinil iontophoresis determine test predict development pulmonary hypertension response PAH-specific therapy .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<criteria>Patients scleroderma cirrhosis . Exclusion criterion include individual young 16 , etiology PAH scleroderma cirrhosis .</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Scleroderma</keyword>
	<keyword>Cirrhosis</keyword>
</DOC>